About: Development and bioanalytical method validation of an LC-MS/MS assay for simultaneous quantitation of 2-alkyl-4(1H)-quinolones for application in bacterial cell culture and lung tissue

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Development and bioanalytical method validation of an LC-MS/MS assay for simultaneous quantitation of 2-alkyl-4(1H)-quinolones for application in bacterial cell culture and lung tissue Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Development and bioanalytical method validation of an LC-MS/MS assay for simultaneous quantitation of 2-alkyl-4(1H)-quinolones for application in bacterial cell culture and lung tissue
Creator	Barbier, Mariette Blackwood, Catherine Brewer, Luke Jones, Jace Kane, Maureen Oglesby-Sherrouse, Amanda
Source	PMC
abstract	Pseudomonas aeruginosa is an opportunistic pathogen that produces numerous exoproducts during infection that help it evade the host immune system and procure nutrients from the host environment. Among these products are a family of secreted 2-alkyl-4(1H)-quinolone metabolites (AQs), which exhibit a range of biological activities. Here, we describe the validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based method for quantifying multiple AQ congeners in complex biological matrices. The assay was validated for selectivity, sensitivity, linearity, accuracy, precision, carryover, dilution integrity, recovery, matrix effects, and various aspects of stability (freeze-thaw, bench-top, long-term storage, and autosampler/post-preparative). Using authentic standards for 6 distinct AQ congeners, we report accurate quantitation within a linear range between 25 and 1000 nmol/L for all of the validated AQ standards. This method was successfully applied to quantify AQ concentrations in P. aeruginosa cell culture and in the lungs of mice infected with P. aeruginosa. Further, we confirmed the presence of unsaturated forms of several AQ congeners in cell culture. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00216-019-02374-0) contains supplementary material, which is available to authorized users.
has issue date	2020-01-29(xsd:dateTime)
bibo:doi	10.1007/s00216-019-02374-0
bibo:pmid	31993728
has license	no-cc
sha1sum (hex)	838d878d50af1421c5f1cead3d55f44074fb73c0
schema:url	https://doi.org/10.1007/s00216-019-02374-0
resource representing a document's title	Development and bioanalytical method validation of an LC-MS/MS assay for simultaneous quantitation of 2-alkyl-4(1H)-quinolones for application in bacterial cell culture and lung tissue
has PubMed Central identifier	PMC7223165
has PubMed identifier	31993728
schema:publication	Anal Bioanal Chem
resource representing a document's body	covid:838d878d50af1421c5f1cead3d55f44074fb73c0#body_text
is schema:about of	named entity 'congeners' named entity 'concentrations' named entity 'quantitation' named entity 'assay' named entity 'biological' named entity 'matrices' named entity 'sensitivity' named entity 'unsaturated' named entity 'congeners' named entity 'P. aeruginosa' named entity 'P. aeruginosa' named entity 'cell culture' named entity 'long-term' named entity 'metabolites' named entity 'LC-MS/MS' named entity 'bioanalytical' named entity 'bacterial cell' named entity 'cell culture' named entity 'interact' named entity 'lungs' named entity 'bacterial cells' named entity 'quantitate' named entity 'SRM' named entity 'enzymatic activity' named entity 'microcentrifuge tubes' named entity 'NIH' named entity 'cell culture' named entity 'orders of magnitude' named entity 'mobile phase' named entity 'lipid membranes' named entity 'P. aeruginosa' named entity 'Staphylococcus aureus' named entity 'analyte' named entity 'P. aeruginosa' named entity 'homogenized' named entity 'congeners' named entity 'acetonitrile' named entity 'homogenates' named entity 'inoculate' named entity 'Mass Spectrometry' named entity 'nalidixic acid' named entity 'P. aeruginosa' named entity 'Cayman Chemical' named entity 'fully saturated' named entity 'National Institute of Health' named entity 'bacterial cultures' named entity 'P. aeruginosa' named entity '4-quinolone' named entity 'P. aeruginosa' named entity 'P. aeruginosa' named entity 'alkyl' named entity 'ACUC' named entity 'P. aeruginosa' named entity 'fully saturated' named entity 'chromosome' named entity 'degree of unsaturation' named entity 'biosynthetic pathway' named entity 'calibration curve' named entity 'congeners' named entity 'Lyophilized' named entity 'nosocomial' named entity 'iron homeostasis' named entity 'matrix effects' named entity 'm/z' named entity 'nonpolar' named entity 'Solvent' named entity 'co-culture' named entity 'antimicrobial activity' named entity 'ethyl acetate' named entity 'cell culture' named entity 'biological replicates' named entity 'pathogenesis' named entity 'Lungs' named entity 'microbial' named entity 'mice' named entity 'm/z'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software